Insys promotes CFO to the helm as Saeed Motahari hits the exit; Gelesis gets OK to market weight loss treatment
→ Saeed Motahari is leaving Insys Therapeutics on the second anniversary of his appointment as CEO. The Purdue Pharma vet is succeeded by his CFO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
